Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
Antioxidants (Basel) ; 11(1)2022 Jan 10.
Article in English | MEDLINE | ID: mdl-35052646

ABSTRACT

Oxidative stress (OS) is implicated in the pathogenesis of several neurodegenerative diseases. We have previously shown that N-acyl dopamines (N-ADA and N-DDA) protect the neural cells of healthy donors and patients with Parkinson's disease from OS. In this study, we assessed the effects of N-acyl dopamines on the expression of neurotrophic factors in human-induced pluripotent stem cell-derived neuronal cultures enriched with dopaminergic neurons under conditions of OS induced by hydrogen peroxide. We showed that hydrogen peroxide treatment increased BDNF but not GDNF mRNA levels, while it did not affect the secretion of corresponding proteins into the culture medium of these cells. Application of N-acyl dopamines promoted BDNF release into the culture medium. Under conditions of OS, N-DDA also increased TRKB, TRKC and RET mRNA levels. Furthermore, N-acyl dopamines prevented cell death 24 h after OS induction and promoted the expression of antioxidant enzymes GPX1, GPX7, SOD1, SOD2 and CAT, as well as reduced the BAX/BCL2 mRNA ratio. These findings indicate that stimulation of the expression of neurotrophic factors and their receptors may underlie the neuroprotective effects of N-acyl dopamines in human neurons.

2.
In Vitro Cell Dev Biol Anim ; 57(5): 531-538, 2021 May.
Article in English | MEDLINE | ID: mdl-34021475

ABSTRACT

Template activating factor-I (TAF-I) is a multifunctional protein involved in various biological processes including the inhibition of histone acetylation, DNA replication, cell cycle regulation, and oncogenesis. Two main TAF-I isoforms with different N-termini, TAF-Iα and TAF-Iß (SET), are expressed in cells. There are numerous data about functional properties of TAF-Iß, whereas the effects of TAF-Iα remain largely unexplored. Here, we employed focus formation and cell proliferation assays, TUNEL staining, cytological analysis, and RT-qPCR to compare the effects of human TAF-Iα and TAF-Iß genes, transiently expressed in Rat2 cells and in Misgurnus fossilis loaches. We found that both TAF-I isoforms possessed equal oncogenic potential in these systems. Furthermore, an overexpression of human TAF-Iα and TAF-Iß in Rat2 cells promoted their proliferation. Accordingly, the mitotic index was increased in the transgenic loaches expressing human TAF-Iα or TAF-Iß. TUNEL assay as well as downregulation of p53 gene and upregulation of bcl-2 gene in these transgenic loaches demonstrated that both isoforms suppressed apoptosis. Thus, TAF-Iα isoform exerts the same oncogenic potential as TAF-Iß, likely by suppressing the apoptosis and promoting cell proliferation.


Subject(s)
Apoptosis , Cell Proliferation , Cell Transformation, Neoplastic/metabolism , DNA-Binding Proteins/physiology , Histone Chaperones/physiology , Animals , Animals, Genetically Modified , Cypriniformes , Fibroblasts/metabolism , Humans , Mitosis , Real-Time Polymerase Chain Reaction
3.
Neurotoxicology ; 82: 108-118, 2021 01.
Article in English | MEDLINE | ID: mdl-33248189

ABSTRACT

The prominent protective effects in diverse neuron injury paradigms exerted by cannabinoids and in particular their endogenously produced species render the endocannabinoid system a promising molecular target in the treatment of neurodegenerative diseases. However, the effects of individual endocannabinoids in human cells remain poorly investigated. Neural derivatives of human induced pluripotent stem cells (iPSC) offer unique opportunities for studying the neuroprotective compounds and development of patient-specific treatment. For the first time the cytotoxic and neuroprotective effects endocannabinoids N-arachidonoyl dopamine (N-ADA) and N-docosahexaenoyl dopamine (N-DDA) were assessed in human neural progenitors and dopamine neurons derived from iPSCs of healthy donors and patients with Parkinson's disease. While the short-term treatment with the investigated compounds in 0.1-10 µM concentration range exerted no toxicity in these cell types, the long-term exposure to 0.1-5 µM N-ADA or N-DDA reduced the survival of human neural progenitors. At the same time, both N-ADA and N-DDA protected neural progenitors and terminally differentiated neurons both from healthy donors and patients with Parkinson's disease against oxidative stress induced by hydrogen peroxide. The observed dramatic difference in the mode of action of N-acyl dopamines points on the possible existence of novel pathogenic mechanism of neurodegeneration induced by prolonged uncompensated production of these substances within neuronal tissue and should also be considered as a precaution in the future development of N-acyl dopamine-based therapeutic drugs.


Subject(s)
Arachidonic Acids/pharmacology , Dopamine/analogs & derivatives , Endocannabinoids/pharmacology , Induced Pluripotent Stem Cells/drug effects , Neuroprotective Agents/pharmacology , Parkinson Disease/metabolism , Arachidonic Acids/toxicity , Cell Death/drug effects , Cell Line , Dopamine/pharmacology , Dopamine/toxicity , Endocannabinoids/toxicity , Fluorescent Antibody Technique , Humans , Neurons/drug effects , Oxidative Stress/drug effects
4.
J Histochem Cytochem ; 67(10): 771-782, 2019 10.
Article in English | MEDLINE | ID: mdl-31294668

ABSTRACT

The copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction is increasingly used for detection of various macromolecules and metabolites in biological samples. Here, we present a detailed analysis of the CuAAC reaction conditions in cells and tissue sections. Using the optimized CuAAC conditions, we have devised a highly sensitive immunostaining technique, based on the tyramide signal amplification/catalyzed reporter deposition (TSA/CARD) method with a novel alkyne tyramide substrate. The described method offers improved detection threshold compared to conventional immunofluorescent staining and produces significantly lower non-specific background than TSA/CARD with fluorescent tyramides.


Subject(s)
Click Chemistry/methods , Fluorescent Antibody Technique/methods , Horseradish Peroxidase , Animals , Azides/chemistry , Boron Compounds/chemistry , Brain Chemistry , Bromodeoxyuridine/analysis , Carbocyanines/chemistry , Cells, Cultured , Copper/chemistry , DNA/chemistry , Deoxyuridine/analogs & derivatives , Deoxyuridine/analysis , Deoxyuridine/chemistry , Female , Fluorescent Dyes/chemistry , Humans , Male , Mice , Pluripotent Stem Cells/chemistry , Sensitivity and Specificity , Tyramine
5.
Mol Biol Rep ; 45(6): 2087-2093, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30203243

ABSTRACT

The tripartite-motif (TRIM)14 protein, one of the TRIM family members, was shown to participate in the antiviral and antibacterial defence. Besides, it appears to play an essential role in the processes of oncogenesis. In some types of human tumour cells, TRIM14 has been shown to inhibit apoptosis, while in others-the overexpression of TRIM14 promotes apoptosis. However, whether TRIM14 mediates apoptosis in the normal cells remains unknown. In the present study, we investigated the possible participation of the human TRIM14 gene and its mutant form (620C > T) in the induction of apoptosis in the transgenic larvae loach Misgurnus fossilis L. We observed that the expression of both forms of TRIM14 gene was accompanied by the increase of the frequency of pyknotic nuclei in fish embryos compared to control groups. Accordingly, using the TUNEL assay, the enhanced apoptosis was revealed upon expression of both forms of TRIM14 gene. The transcription of proapoptotic genes (bax, tp53, and casp9) was significantly increased in transgenic loaches expressing human wild-type TRIM14, but remained unchanged upon expression of its mutant form. In addition, the transcription of c-myc was upregulated in transgenic loaches expressing both forms. Thus, it can be assumed that during embryonic development TRIM14 has a proapoptotic effect on the cells via the activation of c-myc, tp53, and bax genes. Apparently, the mutant TRIM14 directs apoptosis via c-myc by p53-independent mechanism.


Subject(s)
Apoptosis/genetics , Carrier Proteins/genetics , Animals , Animals, Genetically Modified/genetics , Carrier Proteins/physiology , Caspase 9 , Cell Line, Tumor , Cell Transformation, Neoplastic , Cypriniformes/genetics , Cypriniformes/metabolism , Humans , Intracellular Signaling Peptides and Proteins , Polymorphism, Single Nucleotide/genetics , Signal Transduction , Tripartite Motif Proteins , Tumor Suppressor Protein p53 , bcl-2-Associated X Protein
6.
In Vitro Cell Dev Biol Anim ; 50(2): 121-8, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24092016

ABSTRACT

The trim14 (pub, KIAA0129) gene encodes the TRIM14 protein which is a member of the tripartite motif (TRIM) family. Previously, we revealed high expression levels of trim14 in HIV- or SIV-associated lymphomas and demonstrated the influence of trim14 on mesodermal differentiation of mouse embryonic stem cells (mESC). In the present work, to elucidate the role of trim14 in normal and pathological processes in the cell, we used two different types of cells transfected with trim14: mESC and human HEK293. Using subtractive hybridization and real-time PCR, we found a number of genes which expression was elevated in trim14-transfected mESC: hsp90ab1, prr13, pu.1, tnfrsf13c (baff-r), tnfrsf13b (taci), hlx1, hbp1, junb, and pdgfrb. A further analysis of the trim14-transfected mESC at the initial stage of differentiation (embryoid bodies (EB) formation) showed essential changes in the expression of these upregulated genes. The transfection of trim14 into HEK293 also induced an enhanced expression of the several genes upregulated in trim14-transfected mESC (hsp90ab1, prr13, pu.1, tnfrsf13c (baff-r), tnfrsf13b (taci), and hlx1). Summarizing, we found similar genes that participated in trim14-directed processes both in mESC and in HEK293. These results demonstrate the presence of the similar mechanism of trim14 gene action in different types of mammalian cells.


Subject(s)
Cell Differentiation/genetics , Embryonic Stem Cells/metabolism , Trans-Activators/biosynthesis , Transcription, Genetic , Animals , Embryoid Bodies , Gene Expression Regulation, Developmental , HEK293 Cells , Humans , Intracellular Signaling Peptides and Proteins , Mice , Myocytes, Cardiac/metabolism , Trans-Activators/genetics , Tripartite Motif Proteins
SELECTION OF CITATIONS
SEARCH DETAIL